Nimbus clinches $125M raise via big donor-backed private financing round following Bristol Myers' TYK2 approval

More than a year after raising $105 million in a private financing round, Nimbus Therapeutics is back with its next haul as it considers its …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Nim­bus clinch­es $125M raise via big donor-backed pri­vate fi­nanc­ing round fol­low­ing Bris­tol My­er­s' TYK2 ap­proval